{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T01:41:49Z","timestamp":1789263709882,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bioorg.2024.107811","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T22:37:17Z","timestamp":1725748637000},"page":"107811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of tetrahydropyrimidine analogue as GSK-3\u03b2\/A\u03b2 aggregation inhibitor and anti-Alzheimer\u2019s agent"],"prefix":"10.1016","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9877-6349","authenticated-orcid":false,"given":"Sukanya","family":"Sukanya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aina","family":"Bellver-Sanchis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhanwar","family":"Singh Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3n","family":"Leandro Mart\u00ednez Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5523-1979","authenticated-orcid":false,"given":"Jose","family":"Brea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gri\u00f1\u00e1n-Ferr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4912-9441","authenticated-orcid":false,"given":"Ruchi","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107811_b0005","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1192\/bjp.157.1.72","article-title":"Psychiatric Phenomena in Alzheimer\u2019s Disease. I: Disorders of Thought Content","volume":"157","author":"Burns","year":"1990","journal-title":"Br. J. Psychiatry."},{"key":"10.1016\/j.bioorg.2024.107811_b0010","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/scientificamerican1200-76","article-title":"Piecing Together Alzheimer\u2019s","volume":"283","author":"St George-Hyslop","year":"2000","journal-title":"Sci. Am."},{"key":"10.1016\/j.bioorg.2024.107811_b0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JAD-2006-9S317","article-title":"Alzheimer\u2019s disease: The amyloid cascade hypothesis: An update and reappraisal","volume":"9","author":"Hardy","year":"2006","journal-title":"J. of Alzheimer\u2019s. Dis."},{"key":"10.1016\/j.bioorg.2024.107811_b0020","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1755-5949.2010.00177.x","article-title":"The Role of Tau in Alzheimer\u2019s Disease and Related Disorders","volume":"17","author":"Medeiros","year":"2011","journal-title":"CNS. Neurosci. Ther."},{"key":"10.1016\/j.bioorg.2024.107811_b0025","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: The trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA. Neurol."},{"key":"10.1016\/j.bioorg.2024.107811_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00025","article-title":"Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer\u2019s Disease","volume":"12","author":"Kametani","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bioorg.2024.107811_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2015.06.008","article-title":"Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer\u2019s disease","volume":"52","author":"Barage","year":"2015","journal-title":"Neuropeptides."},{"key":"10.1016\/j.bioorg.2024.107811_b0040","first-page":"1","article-title":"What Are the bona fide GSK3 Substrates?","volume":"2011","author":"Sutherland","year":"2011","journal-title":"Int. J. Alzheimers. Dis."},{"key":"10.1016\/j.bioorg.2024.107811_b0045","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1471-4159.2010.06988.x","article-title":"Evidence that glycogen synthase kinase-3 isoforms have distinct substrate preference in the brain","volume":"115","author":"Soutar","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bioorg.2024.107811_b0050","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer\u2019s disease","volume":"104","author":"Hooper","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bioorg.2024.107811_b0055","article-title":"Roles of Glycogen Synthase Kinase 3 in Alzheimer \u2019s Disease","volume":"864\u2013879","author":"Cai","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bioorg.2024.107811_b0060","doi-asserted-by":"crossref","first-page":"15823","DOI":"10.1074\/jbc.M610708200","article-title":"GSK3 NL Activity Modifies the Localization and Function of Presenilin 1 *","volume":"282","author":"Uemura","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107811_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2018.00178","article-title":"Highlights in BACE1 Inhibitors for Alzheimer\u2019s Disease Treatment","volume":"6","author":"Coimbra","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2024.107811_b0070","article-title":"Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3","volume":"8","author":"Koh","year":"2007","journal-title":"Brain. Res."},{"key":"10.1016\/j.bioorg.2024.107811_b0075","doi-asserted-by":"crossref","first-page":"40162","DOI":"10.1074\/jbc.M308243200","article-title":"\u0392-Amyloid Induces Paired Helical Filament-Like Tau Filaments in Tissue Culture","volume":"278","author":"Ferrari","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107811_b0080","article-title":"Alzheimer\u2019s disease drug development pipeline: 2021","volume":"7","author":"Cummings","year":"2021","journal-title":"Alzheimer\u2019s. Dement."},{"key":"10.1016\/j.bioorg.2024.107811_b0085","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/anie.201410456","article-title":"Multitarget Drug Discovery for Alzheimer\u2019s Disease: Triazinones as BACE-1 and GSK-3\u03b2 Inhibitors, Angew","volume":"54","author":"Prati","year":"2015","journal-title":"Chem. Int."},{"key":"10.1016\/j.bioorg.2024.107811_b0090","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1021\/acschemneuro.5b00121","article-title":"3,4-Dihydro-1,3,5-triazin-2(1 H)-ones as the First Dual BACE-1\/GSK-3\u03b2 Fragment Hits against Alzheimer\u2019s Disease","volume":"6","author":"Prati","year":"2015","journal-title":"ACS. Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2024.107811_b0095","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ejmech.2017.06.017","article-title":"First dual AK\/GSK-3\u03b2 inhibitors endowed with antioxidant properties as multifunctional, potential neuroprotective agents","volume":"138","author":"Brogi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107811_b0100","doi-asserted-by":"crossref","first-page":"7640","DOI":"10.1021\/acs.jmedchem.8b00610","article-title":"Tau-Centric Multitarget Approach for Alzheimer\u2019s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3\u03b2 and Tau-Aggregation Inhibitors","volume":"61","author":"Gandini","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107811_b0105","first-page":"171","article-title":"Dual GSK-3\u03b2\/AChE Inhibitors as a New Strategy for Multitargeting Anti-Alzheimer\u2019s Disease Drug Discovery, ACS. Med","volume":"9","author":"Jiang","year":"2018","journal-title":"Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107811_b0110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejmech.2018.12.063","article-title":"Design, biological evaluation and X-ray crystallography of nanomolar multifunctional ligands targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3","volume":"168","author":"Oukoloff","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107811_b0115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejmech.2019.02.001","article-title":"Synthesis and evaluation of novel GSK-3\u03b2 inhibitors as multifunctional agents against Alzheimer\u2019s disease","volume":"167","author":"Shi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107811_b0120","first-page":"469","article-title":"Discovery of the First-in-Class GSK-3\u03b2\/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer\u2019s Disease, ACS. Med","volume":"10","author":"de Simone","year":"2019","journal-title":"Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107811_b0125","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/cmdc.201800778","article-title":"A Triazolotriazine-Based Dual GSK-3\u03b2\/CK-1\u03b4 Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition","volume":"14","author":"Redenti","year":"2019","journal-title":"ChemMedChem."},{"key":"10.1016\/j.bioorg.2024.107811_b0130","doi-asserted-by":"crossref","first-page":"8534","DOI":"10.1021\/jm100941j","article-title":"Discovery of novel GSK-3\u03b2 inhibitors with potent in vitro and in Vivo activities and excellent brain permeability using combined ligand- and structure-based virtual screening","volume":"53","author":"Khanfar","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107811_b0135","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1016\/j.bmcl.2013.03.119","article-title":"Synthesis and evaluation of 8-amino-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives as glycogen synthase kinase-3 (GSK-3) inhibitors","volume":"23","author":"Chun","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107811_b0140","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ejmech.2016.09.058","article-title":"Natural and synthetic bioactive inhibitors of glycogen synthase kinase","volume":"125","author":"Khan","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107811_b0145","doi-asserted-by":"crossref","first-page":"6928","DOI":"10.1016\/j.bmcl.2013.09.021","article-title":"6-(4-Pyridyl)pyrimidin-4(3H)-ones as CNS penetrant glycogen synthase kinase-3\u03b2 inhibitors","volume":"23","author":"Uehara","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107811_b0150","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.bmcl.2015.01.005","article-title":"Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)-pyrimidin-4(3H)-ones as orally-active GSK-3\u03b2 inhibitors for Alzheimer\u2019s disease","volume":"25","author":"Fukunaga","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107811_b0155","doi-asserted-by":"crossref","first-page":"6933","DOI":"10.1016\/j.bmcl.2013.09.020","article-title":"2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; A new class of potent, selective and orally active glycogen synthase kinase-3\u03b2 inhibitors","volume":"23","author":"Fukunaga","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107811_b0160","doi-asserted-by":"crossref","unstructured":"S. Mohana Roopan, R. Sompalle, Synthetic chemistry of pyrimidines and fused pyrimidines: A review, Synth. Commun. 46 (2016) 645\u2013672. 10.1080\/00397911.2016.1165254.","DOI":"10.1080\/00397911.2016.1165254"},{"key":"10.1016\/j.bioorg.2024.107811_b0165","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4103\/0250-474X.34540","article-title":"Pyrimidine as antiinflammatory agent: A review","volume":"69","author":"Amir","year":"2007","journal-title":"Indian. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2024.107811_b0170","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/jhet.5570270229","article-title":"Synthesis of 3-substituted-4-phenyl-2-thioxo-1,2,3,4,5,6,7,8-octahydrobenzo[4,5]thieno[2,3-\u00e1]pyrimidines","volume":"27","author":"Vega","year":"1990","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2024.107811_b0175","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1021\/jo01031a037","article-title":"Cyclization of Isothiocyanates as a Route to Phthalic and Homophthalic Acid Derivatives 1,2","volume":"29","author":"Smith","year":"1964","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2024.107811_b0180","doi-asserted-by":"crossref","unstructured":"P.F. Juby, T.W. Hudyma, M. Brown, J.M. Essery, R.A. Partyka, Antiallergy agents. 1. 1,6-Dihydro-6-oxo-2-phenylpyrimidine-5-carboxylic acids and esters, J. Med. Chem. 22 (1979) 263\u2013269. 10.1021\/jm00189a009.","DOI":"10.1021\/jm00189a009"},{"key":"10.1016\/j.bioorg.2024.107811_b0185","doi-asserted-by":"crossref","unstructured":"Sk.A. Rahaman, Y. Rajendra Pasad, P. Kumar, B. Kumar, Synthesis and anti-histaminic activity of some novel pyrimidines, Saudi. Pharm. J. 17 (2009) 255\u2013258. 10.1016\/j.jsps.2009.08.001.","DOI":"10.1016\/j.jsps.2009.08.001"},{"key":"10.1016\/j.bioorg.2024.107811_b0190","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jccs.201190056","article-title":"Synthesis, Antioxidant, Antituomer Activities of Some New Thiazolopyrimidines, Pyrrolothiazolopyrimidines and Triazolopyrrolothiazolopyrimidines Derivatives","volume":"58","author":"Abu-Hashem","year":"2011","journal-title":"J. Chin. Chem. Soc."},{"key":"10.1016\/j.bioorg.2024.107811_b0195","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0223-5234(92)90009-P","article-title":"Synthesis, antimicrobial and antiviral activities of isotrimethoprim and some related derivatives","volume":"27","author":"Botta","year":"1992","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107811_b0200","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ejmech.2004.06.011","article-title":"Organoiodine (III) mediated synthesis of 3-aryl\/hetryl-5,7-dimethyl-1,2,4-triazolo[4,3-a]pyrimidines as antibacterial agents","volume":"39","author":"Prakash","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107811_b0205","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/S0968-0896(02)00107-4","article-title":"Synthesis and biological activity of novel pyrimidinone containing thiazolidinedione derivatives","volume":"10","author":"Madhavan","year":"2002","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107811_b0210","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0960-894X(00)00091-3","article-title":"Suitably functionalised pyrimidines as potential antimycotic agents","volume":"10","author":"Agarwal","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107811_b0215","doi-asserted-by":"crossref","unstructured":"V.J. RAM, N. HAQUE, P.Y. GURU, ChemInform Abstract: Chemotherapeutic Agents: Synthesis and Leishmanicidal Activity of Carbazolylpyrimidines., ChemInform. 24 (2010) no-no. 10.1002\/chin.199316208.","DOI":"10.1002\/chin.199316208"},{"key":"10.1016\/j.bioorg.2024.107811_b0220","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bmcl.2008.09.067","article-title":"Synthesis and biological evaluation of novel 2,4,5-substituted pyrimidine derivatives for anticancer activity","volume":"19","author":"Xie","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107811_b0225","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1023\/A:1010398911988","article-title":"Synthesis and Antitumor Activity of Some Disubstituted 5-(3-Methyl-4-alkoxybenzyl)pyrimidines","volume":"34","author":"Kaldrikyan","year":"2000","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.bioorg.2024.107811_b0230","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/dkf037","article-title":"Bicyclic pyrimidine nucleoside analogues (BCNAs) as highly selective and potent inhibitors of varicella-zoster virus replication","volume":"50","author":"Balzarini","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioorg.2024.107811_b0235","doi-asserted-by":"crossref","unstructured":"D.R. Hannah, M.F.G. Stevens, Structural Studies on Bioactive Compounds. Part 38. 1 Reactions of 5-Aminoimidazole-4-Carboxamide: Synthesis of Imidazo[1,5- a ]Quinazoline-3-Carboxamides, J. Chem. Res. 2003 (2003) 398\u2013401. 10.3184\/030823403103174533.","DOI":"10.3184\/030823403103174533"},{"key":"10.1016\/j.bioorg.2024.107811_b0240","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ejmech.2005.03.019","article-title":"Molecular design, synthesis, and hypoglycemic and hypolipidemic activities of novel pyrimidine derivatives having thiazolidinedione","volume":"40","author":"Lee","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107811_b0245","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ardp.200500982","article-title":"Synthesis and Reactions of Some New Substituted Pyridine and Pyrimidine Derivatives as Analgesic, Anticonvulsant and Antiparkinsonian Agents","volume":"338","author":"Amr","year":"2005","journal-title":"Arch. Pharm (weinheim)"},{"key":"10.1016\/j.bioorg.2024.107811_b0250","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1021\/acschemneuro.6b00380","article-title":"Development of Phenothiazine-Based Theranostic Compounds That Act Both as Inhibitors of \u03b2-Amyloid Aggregation and as Imaging Probes for Amyloid Plaques in Alzheimer\u2019s Disease","volume":"8","author":"Dao","year":"2017","journal-title":"ACS. Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2024.107811_b0255","doi-asserted-by":"crossref","first-page":"9215","DOI":"10.1002\/anie.200704051","article-title":"Rhodanine-Based Tau Aggregation Inhibitors in Cell Models of Tauopathy, Angew","volume":"46","author":"Bulic","year":"2007","journal-title":"Chem. Int."},{"key":"10.1016\/j.bioorg.2024.107811_b0260","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00044-010-9481-4","article-title":"Synthesis, characterization, anticancer activity, and QSAR-studies of some new tetrahydropyrimidines","volume":"20","author":"Desai","year":"2011","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2024.107811_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115468","article-title":"Synthesis and evaluation of 7-azaindole derivatives bearing benzocycloalkanone motifs as protein kinase inhibitors","volume":"28","author":"Qhobosheane","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107811_b0270","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00044-022-02912-z","article-title":"Identification of CNS compatible small molecules as glycogen synthase kinase-3\u03b2 (GSK-3\u03b2) inhibitors through structure-based virtual screening","volume":"31","author":"Sukanya","year":"2022","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2024.107811_b0275","doi-asserted-by":"crossref","first-page":"12931","DOI":"10.1038\/s41598-017-12788-4","article-title":"6E11, a highly selective inhibitor of Receptor-Interacting Protein Kinase 1, protects cells against cold hypoxia-reoxygenation injury","volume":"7","author":"Delehouz\u00e9","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2024.107811_b0280","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1021\/acs.jmedchem.0c02064","article-title":"From Synthetic Simplified Marine Metabolite Analogues to New Selective Allosteric Inhibitor of Aurora B Kinase","volume":"64","author":"Juillet","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107811_b0285","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/genetics\/77.1.71","article-title":"The genetics of Caenorhabditis Elegans","volume":"77","author":"Brenner","year":"1974","journal-title":"Genetics."},{"key":"10.1016\/j.bioorg.2024.107811_b0290","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1111\/bph.15478","article-title":"Disease-modifying treatment with I 2 imidazoline receptor ligand LSL60101 in an Alzheimer\u2019s disease mouse model: a comparative study with donepezil","volume":"178","author":"Vasilopoulou","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2024.107811_b0295","doi-asserted-by":"crossref","unstructured":"A.P. Saraswati, S.M. Ali Hussaini, N.H. Krishna, B.N. Babu, A. Kamal, Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions, Eur. J. Med. Chem. 144 (2018) 843\u2013858. 10.1016\/j.ejmech.2017.11.103.","DOI":"10.1016\/j.ejmech.2017.11.103"},{"key":"10.1016\/j.bioorg.2024.107811_b0300","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.669728","article-title":"Benzohydrazide and Phenylacetamide Scaffolds: New Putative ParE Inhibitors","volume":"9","author":"Yele","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bioorg.2024.107811_b0305","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2174\/1570178615666180808120658","article-title":"Chemistry and Pharmacology of Acetanilide Derivatives: A Mini Review","volume":"16","author":"Singh","year":"2018","journal-title":"Lett. Org. Chem."},{"key":"10.1016\/j.bioorg.2024.107811_b0310","doi-asserted-by":"crossref","unstructured":"M. Arfeen, S. Bhagat, R. Patel, S. Prasad, I. Roy, A.K. Chakraborti, P. v. Bharatam, Design, synthesis and biological evaluation of 5-benzylidene-2-iminothiazolidin-4-ones as selective GSK-3\u03b2 inhibitors, Eur. J. Med. Chem. 121 (2016) 727\u2013736. 10.1016\/j.ejmech.2016.04.075.","DOI":"10.1016\/j.ejmech.2016.04.075"},{"key":"10.1016\/j.bioorg.2024.107811_b0315","doi-asserted-by":"crossref","unstructured":"M. Grossman, E. Adler, Protein Kinase Inhibitors - Selectivity or Toxicity? [Internet]. Protein Kinases - Promising Targets for Anticancer Drug Research. IntechOpen. 2021. 10.5772\/intechopen.98640.","DOI":"10.5772\/intechopen.98640"},{"key":"10.1016\/j.bioorg.2024.107811_b0320","doi-asserted-by":"crossref","unstructured":"A. Bellver\u2010Sanchis, B. Singh Choudhary, J. Companys\u2010Alemany, Sukanya, P.A. \u00c1vila\u2010L\u00f3pez, A.L. Mart\u00ednez Rodr\u00edguez, J.M. Brea Floriani, R. Malik, M. Pall\u00e0s, B. P\u00e9rez, C. Gri\u00f1\u00e1n\u2010Ferr\u00e9, Structure\u2010Based Virtual Screening and in\u2005vitro and in\u2005vivo Analyses Revealed Potent Methyltransferase G9a Inhibitors as Prospective Anti\u2010Alzheimer\u2019s Agents, ChemMedChem. 17 (2022). 10.1002\/cmdc.202200002.","DOI":"10.1002\/cmdc.202200002"},{"key":"10.1016\/j.bioorg.2024.107811_b0325","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/brainsci10110838","article-title":"Caenorhabditis elegans Models to Investigate the Mechanisms Underlying Tau Toxicity in Tauopathies","volume":"10","author":"Natale","year":"2020","journal-title":"Brain. Sci."},{"key":"10.1016\/j.bioorg.2024.107811_b0330","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/hmg\/dds190","article-title":"Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity","volume":"21","author":"Fatouros","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bioorg.2024.107811_b0335","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/j.ddtec.2012.02.002","article-title":"Alzheimer\u2019s disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for \u03b2-amyloid peptide-induced toxicity","volume":"10","author":"Lublin","year":"2013","journal-title":"Drug. Discov. Today. Technol."},{"key":"10.1016\/j.bioorg.2024.107811_b0340","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.046110","article-title":"Modeling neurodegeneration in Caenorhabditis elegans","volume":"13","author":"Caldwell","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bioorg.2024.107811_b0345","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1021\/acs.jmedchem.5b01550","article-title":"Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors","volume":"59","author":"Luo","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107811_b0350","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.1016\/j.bmc.2009.06.054","article-title":"The marine natural-derived inhibitors of glycogen synthase kinase-3\u03b2 phenylmethylene hydantoins: In vitro and in vivo activities and pharmacophore modeling","volume":"17","author":"Khanfar","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107811_bib351","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104046","article-title":"Toward structure\u2013multiple activity relationships (SMARts) using computational approaches: A polypharmacological perspective","volume":"29","author":"L\u00f3pez-L\u00f3pez","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2024.107811_bib352","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejmech.2019.05.020","article-title":"Multi-target design strategies for the improved treatment of Alzheimer's disease","volume":"176","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107811_bib353","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107152","article-title":"A comprehensive review of multi-target directed ligands in the treatment of Alzheimer\u2019s disease","volume":"144","author":"Pathak","year":"2024","journal-title":"Bioorg. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824007168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824007168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:22:12Z","timestamp":1738203732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824007168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":73,"alternative-id":["S0045206824007168"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107811","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of tetrahydropyrimidine analogue as GSK-3\u03b2\/A\u03b2 aggregation inhibitor and anti-Alzheimer\u2019s agent","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107811"}}